178 related articles for article (PubMed ID: 28261964)
1. Synthesis and Cytotoxicity Evaluation of C4- and C5-Modified Analogues of the α,β-Unsaturated Lactone of Pironetin.
Huang DS; Wong HL; Georg GI
ChemMedChem; 2017 Apr; 12(7):520-528. PubMed ID: 28261964
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of C2 functionalized analogs of the α-tubulin-binding natural product pironetin.
Huang DS; Wong HL; Georg GI
Bioorg Med Chem Lett; 2018 Sep; 28(16):2789-2793. PubMed ID: 29138028
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of truncated α-tubulin-binding pironetin analogues lacking alkyl pendants in the side chain or the dihydropyrone ring.
Paños J; Díaz-Oltra S; Sánchez-Peris M; García-Pla J; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Org Biomol Chem; 2013 Sep; 11(35):5809-26. PubMed ID: 23892508
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of simplified pironetin analogues with modifications in the side chain and the lactone ring.
Roldán S; Cardona A; Conesa L; Murga J; Falomir E; Carda M; Marco JA
Org Biomol Chem; 2016 Dec; 15(1):220-232. PubMed ID: 27901163
[TBL] [Abstract][Full Text] [Related]
5. Identification of the Metabolic Profile of the α-Tubulin-Binding Natural Product (-)-Pironetin.
Coulup SK; Huang DS; Wong HL; Georg GI
J Med Chem; 2019 Feb; 62(3):1684-1689. PubMed ID: 30693770
[TBL] [Abstract][Full Text] [Related]
6. The anticancer natural product pironetin selectively targets Lys352 of alpha-tubulin.
Usui T; Watanabe H; Nakayama H; Tada Y; Kanoh N; Kondoh M; Asao T; Takio K; Watanabe H; Nishikawa K; Kitahara T; Osada H
Chem Biol; 2004 Jun; 11(6):799-806. PubMed ID: 15217613
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin.
Paterson I; Naylor GJ; Fujita T; Guzmán E; Wright AE
Chem Commun (Camb); 2010 Jan; 46(2):261-3. PubMed ID: 20024345
[TBL] [Abstract][Full Text] [Related]
8. Studies of (-)-pironetin binding to α-tubulin: conformation, docking, and molecular dynamics.
Bañuelos-Hernández AE; Mendoza-Espinoza JA; Pereda-Miranda R; Cerda-García-Rojas CM
J Org Chem; 2014 May; 79(9):3752-64. PubMed ID: 24761989
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of pironetin analogues with simplified structure and study of their interactions with microtubules.
Marco JA; García-Pla J; Carda M; Murga J; Falomir E; Trigili C; Notararigo S; Díaz JF; Barasoain I
Eur J Med Chem; 2011 May; 46(5):1630-7. PubMed ID: 21396747
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of phenylpironetin analogs and the metabolic fate of pironetin and phenylpironetin.
Noman MAA; Huang DS; Coulup SK; Syeda SS; Henry ; Wong L; Georg GI
Bioorg Chem; 2022 Aug; 125():105915. PubMed ID: 35660840
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of pironetin and related analogs: studies on structure-activity relationships as tubulin assembly inhibitors.
Watanabe H; Watanabe H; Usui T; Kondoh M; Osada H; Kitahara T
J Antibiot (Tokyo); 2000 May; 53(5):540-5. PubMed ID: 10908119
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic activities of goniothalamins and derivatives.
Weber A; Döhl K; Sachs J; Nordschild ACM; Schröder D; Kulik A; Fischer T; Schmitt L; Teusch N; Pietruszka J
Bioorg Med Chem; 2017 Nov; 25(22):6115-6125. PubMed ID: 28214230
[TBL] [Abstract][Full Text] [Related]
13. High-content analysis of cancer-cell-specific apoptosis and inhibition of in vivo angiogenesis by synthetic (-)-pironetin and analogs.
Vogt A; McPherson PA; Shen X; Balachandran R; Zhu G; Raccor BS; Nelson SG; Tsang M; Day BW
Chem Biol Drug Des; 2009 Oct; 74(4):358-68. PubMed ID: 19691472
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and in vitro evaluation against human cancer cells of 5-methyl-5-styryl-2,5-dihydrofuran-2-ones, a new series of goniothalamin analogues.
Bruder M; Vendramini-Costa DB; de Carvalho JE; Pilli RA
Bioorg Med Chem; 2013 Sep; 21(17):5107-17. PubMed ID: 23876338
[TBL] [Abstract][Full Text] [Related]
15. New antitumour agents with α,β-unsaturated δ-lactone scaffold: Synthesis and antiproliferative activity of (-)-cleistenolide and analogues.
Benedeković G; Kovačević I; Popsavin M; Francuz J; Kojić V; Bogdanović G; Popsavin V
Bioorg Med Chem Lett; 2016 Jul; 26(14):3318-3321. PubMed ID: 27231128
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of a simplified fluorescently labeled discodermolide as a molecular probe to study the binding of discodermolide to tubulin.
Qi J; Blanden AR; Bane S; Kingston DG
Bioorg Med Chem; 2011 Sep; 19(17):5247-54. PubMed ID: 21802957
[TBL] [Abstract][Full Text] [Related]
17. The Mechanism of the Interactions of Pironetin Analog/Combretastatin A-4 Hybrids with Tubulin.
Torijano-Gutiérrez S; Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Arch Pharm (Weinheim); 2015 Aug; 348(8):541-7. PubMed ID: 26085125
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents.
Abuhaie CM; Bîcu E; Rigo B; Gautret P; Belei D; Farce A; Dubois J; Ghinet A
Bioorg Med Chem Lett; 2013 Jan; 23(1):147-52. PubMed ID: 23200248
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of pironetin analogue/colchicine hybrids and study of their cytotoxic activity and mechanisms of interaction with tubulin.
Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
J Med Chem; 2014 Dec; 57(24):10391-403. PubMed ID: 25426924
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of the analogs of plocabulin and their preliminary structure-activity relationship study.
Wang L; Li X; Cui H; Lei X; Liu H; Wang Q; Li Y
Bioorg Med Chem Lett; 2021 Nov; 51():128355. PubMed ID: 34508844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
